Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001410287 | SCV001612332 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-09-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002554011 | SCV003624248 | uncertain significance | Inborn genetic diseases | 2022-05-02 | criteria provided, single submitter | clinical testing | The c.4543-5A>C intronic alteration consists of a A to C substitution 5 nucleotides before coding exon 22 in the DYNC1H1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003963299 | SCV004776502 | likely benign | DYNC1H1-related disorder | 2022-12-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |